Breastfeeding_Doctor_Ltd_30_Mar_2022_set_of_accounts_for_filing.html

Breastfeeding_Doctor_Ltd_30_Mar_2022_set_of_accounts_for_filing.html


1 April 2021 v2023.2.1 micro_entity_frs_105_v1_0_9 filingSoftwarefalsetruetruetrueNo description of principal activitytruexbrli:purexbrli:sharesiso4217:GBP132350262021-04-012022-03-30132350262022-03-3013235026core:WithinOneYear2022-03-3013235026core:AfterOneYear2022-03-3013235026bus:RegisteredOffice2021-04-012022-03-3013235026bus:Director12021-04-012022-03-3013235026bus:Director22021-04-012022-03-301323502612021-04-012022-03-3013235026countries:EnglandWales2021-04-012022-03-3013235026bus:AuditExemptWithAccountantsReport2021-04-012022-03-3013235026bus:PrivateLimitedCompanyLtd2021-04-012022-03-3013235026bus:Micro-entities2021-04-012022-03-3013235026bus:FullAccounts2021-04-012022-03-30
Company registration number:
13235026
Breastfeeding Doctor Ltd
Unaudited Filleted Financial Statements for the period ended
30 March 2022
Breastfeeding Doctor Ltd
Statement of Financial Position
30 March 2022
30 Mar 2022
£
Fixed assets
8,498
 
 
Current assets
59,791
 
Prepayments and accrued income
4,813
 
Creditors: amounts falling due within one year
(37,242
)
Net current assets
27,362
 
Total assets less current liabilities
35,860
 
Creditors: amounts falling due after more than one year
(29,688
)
Accruals and deferred income
(5,890
)
Net assets
282
 
 
Capital and reserves
282
 

Notes to the Financial Statements

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
3 Market Place
,
Falloden Way
,
London
,
NW11 6LB
, United Kingdom.

2 Average number of employees

The average number of persons employed by the company during the period was
2
.
For the period ending
30 March 2022
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
22 February 2023
, and are signed on behalf of the board by:
Dr Sharon Silberstein
Mr Joel Silberstein
DirectorDirector
Company registration number:
13235026